Obstetrics and gynecology
-
Obstetrics and gynecology · Aug 2021
Randomized Controlled TrialEducational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery: A Randomized Controlled Trial.
To evaluate whether viewing an educational video on pain management reduces opioid use after cesarean delivery. ⋯ ClinicalTrials.gov, NCT03959969.
-
Obstetrics and gynecology · Feb 2021
Randomized Controlled Trial Multicenter Study Comparative StudyMaternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients.
To compare risks of maternal and perinatal outcomes by completed week of gestation from 39 weeks in low-risk nulliparous patients undergoing expectant management. ⋯ In expectantly managed low-risk nulliparous participants, the frequency of medically indicated induction of labor, and the risks of cesarean delivery but not the perinatal composite outcome, increased significantly from 39 to 42 weeks of gestation.
-
Obstetrics and gynecology · Nov 2020
Randomized Controlled TrialAssociation of a Pediatric Gynecology eLearning Module With Resident Knowledge and Clinical Skills: A Randomized Controlled Trial.
To assess whether a pediatric and adolescent gynecology electronic learning (eLearning) module improves knowledge and clinical performance among obstetrics and gynecology residents. ⋯ Our pediatric and adolescent gynecology eLearning module resulted in improved short-term resident knowledge and simulated clinical skills among obstetrics and gynecology residents. Applying this learning technique in other programs may help address deficiencies in pediatric and adolescent gynecology education and training.
-
Obstetrics and gynecology · Aug 2020
Randomized Controlled TrialEffect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial.
To estimate the effect of providing women with a latex diaphragm, lubricant gel, and male condoms (intervention) compared with condoms alone (control) on human papillomavirus (HPV) incidence and clearance. ⋯ I.
-
Obstetrics and gynecology · Jun 2020
Randomized Controlled Trial Multicenter StudyElagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
To investigate the safety and efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy for up to 12 months in women with heavy menstrual bleeding associated with uterine leiomyomas. ⋯ AbbVie Inc funded this study.